InvestSMART

Dorsavi Ltd (ASX: DVL) - Announcements

- Current share price for DVL : $0.026

ASX company news and announcements for Dorsavi Ltd (DVL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dorsavi Ltd (DVL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dorsavi Ltd (DVL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dorsavi Ltd (DVL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$32 dorsaVi signs New England Patriots (NFL) and two US Universi 18 Aug 2015 9:37AM $0.280 $0.026 fallen by 90.71%
$32 dorsaVi signs Crown Resorts, its largest contract to date. 17 Aug 2015 9:24AM $0.260 $0.026 fallen by 90%
$32 dorsaVi Conference Presentation 17 Jul 2015 8:26AM $0.290 $0.026 fallen by 91.03%
$32 Appendix 4C - quarterly 16 Jul 2015 9:56AM $0.280 $0.026 fallen by 90.71%
$32 Resignation of Chief Financial Officer 15 Jul 2015 9:32AM $0.275 $0.026 fallen by 90.55%
$32 dorsaVi signs NFL teams to use ViPerform 9 Jul 2015 9:28AM $0.290 $0.026 fallen by 91.03%
$32 ViSafe assessment on US police department 24 Jun 2015 9:48AM $0.260 $0.026 fallen by 90%
$32 dorsaVi CPT coding and US reimbursement strategy 19 Jun 2015 9:40AM $0.260 $0.026 fallen by 90%
$32 dorsaVi signs UK physiotherapy network 2 Jun 2015 9:43AM $0.270 $0.026 fallen by 90.37%
$32 Clinical Trial using dorsaVi shows reduction in back pain 1 Jun 2015 11:33AM $0.275 $0.026 fallen by 90.55%
$32 FDA approves ViMove for expanded US use 1 Jun 2015 10:01AM $0.275 $0.026 fallen by 90.55%
$32 ViPerform adopted by two NBA teams 28 May 2015 9:17AM $0.230 $0.026 fallen by 88.70%
$32 dorsaVi Investor Update May 2015 25 May 2015 3:01PM $0.290 $0.026 fallen by 91.03%
$32 dorsaVi secures first UK ViSafe deals 21 May 2015 9:57AM $0.280 $0.026 fallen by 90.71%
$32 dorsaVi signs first OHS deal in the US 7 May 2015 10:01AM $0.300 $0.026 fallen by 91.33%
$32 Appendix 4C - quarterly 30 Apr 2015 9:50AM $0.300 $0.026 fallen by 91.33%
$32 dorsaVi announces partnerships with the NHS hospitals 27 Mar 2015 10:02AM $0.325 $0.026 fallen by 92%
$32 Half Yearly Report and Accounts 27 Feb 2015 10:04AM n/a $0.026 n/a
$32 Appendix 4C - quarterly 30 Jan 2015 9:15AM n/a $0.026 n/a
$32 Appendix 4C - quarterly 30 Oct 2014 4:09PM $0.400 $0.026 fallen by 93.50%
$32 Preliminary Final Report 29 Aug 2014 9:35AM $0.430 $0.026 fallen by 93.95%
$32 Appendix 4C - quarterly 31 Jul 2014 9:50AM $0.485 $0.026 fallen by 94.64%
$32 dorsaVi welcomes first US sale 23 Jul 2014 8:29AM $0.450 $0.026 fallen by 94.22%
$32 ViMove receives 510k designation in US 15 Jul 2014 9:58AM $0.445 $0.026 fallen by 94.16%
$32 ViMove approved for sale in New Zealand 8 Jul 2014 9:11AM $0.430 $0.026 fallen by 93.95%

726 - 750 of 756 results

Page 30 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.